KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Return on Sales: 2011-2024

Historic Return on Sales for Esperion Therapeutics (ESPR) over the last 13 years, with Dec 2024 value amounting to -0.01%.

  • Esperion Therapeutics' Return on Sales fell 21.00% to -0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.35%, marking a year-over-year decrease of 21.00%. This contributed to the annual value of -0.01% for FY2024, which is 183.00% up from last year.
  • Esperion Therapeutics' Return on Sales amounted to -0.01% in FY2024, which was up 99.21% from -1.84% recorded in FY2023.
  • Over the past 5 years, Esperion Therapeutics' Return on Sales peaked at -0.01% during FY2024, and registered a low of -3.48% during FY2021.
  • Moreover, its 3-year median value for Return on Sales was -1.84% (2023), whereas its average is -1.66%.
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by 285bps in 2021, then soared by 183bps in 2024.
  • Over the past 5 years, Esperion Therapeutics' Return on Sales (Yearly) stood at -0.63% in 2020, then plummeted by 285bps to -3.48% in 2021, then spiked by 35bps to -3.13% in 2022, then skyrocketed by 129bps to -1.84% in 2023, then surged by 183bps to -0.01% in 2024.